86 related articles for article (PubMed ID: 25085538)
1. Long-term therapeutic effects of mesenchymal stem cells compared to dexamethasone on recurrent experimental autoimmune uveitis of rats.
Zhang L; Zheng H; Shao H; Nian H; Zhang Y; Bai L; Su C; Liu X; Dong L; Li X; Zhang X
Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):5561-71. PubMed ID: 25125599
[TBL] [Abstract][Full Text] [Related]
2. Tolerance Induction in Relation to the Eye.
Gery I; Caspi RR
Front Immunol; 2018; 9():2304. PubMed ID: 30356688
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic induction of antigen-specific immune tolerance.
Kenison JE; Stevens NA; Quintana FJ
Nat Rev Immunol; 2024 May; 24(5):338-357. PubMed ID: 38086932
[TBL] [Abstract][Full Text] [Related]
4. Development of Clarstatin, a Novel Drug Lead for the Therapy of Autoimmune Uveitis.
Merzbach S; Hoffman A; Lazarovici P; Gilon C; Amer R
Pharmaceutics; 2024 May; 16(6):. PubMed ID: 38931845
[TBL] [Abstract][Full Text] [Related]
5. Indole-3-carbinol, a plant nutrient and AhR-Ligand precursor, supports oral tolerance against OVA and improves peanut allergy symptoms in mice.
Hammerschmidt-Kamper C; Biljes D; Merches K; Steiner I; Daldrup T; Bol-Schoenmakers M; Pieters RHH; Esser C
PLoS One; 2017; 12(6):e0180321. PubMed ID: 28666018
[TBL] [Abstract][Full Text] [Related]
6. Plant-based vaccines for oral delivery of type 1 diabetes-related autoantigens: Evaluating oral tolerance mechanisms and disease prevention in NOD mice.
Posgai AL; Wasserfall CH; Kwon KC; Daniell H; Schatz DA; Atkinson MA
Sci Rep; 2017 Feb; 7():42372. PubMed ID: 28205558
[TBL] [Abstract][Full Text] [Related]
7. Rat models of autoimmune uveitis.
Wildner G; Diedrichs-Mohring M; Thurau SR
Ophthalmic Res; 2008; 40(3-4):141-4. PubMed ID: 18421228
[TBL] [Abstract][Full Text] [Related]
8. A new small molecule for treating inflammation and chorioretinal neovascularization in relapsing-remitting and chronic experimental autoimmune uveitis.
Diedrichs-Möhring M; Leban J; Strobl S; Obermayr F; Wildner G
Invest Ophthalmol Vis Sci; 2014 Dec; 56(2):1147-57. PubMed ID: 25515581
[TBL] [Abstract][Full Text] [Related]
9. Oral tolerance in experimental autoimmune uveoretinitis. Distinct mechanisms of resistance are induced by low dose vs high dose feeding protocols.
Gregerson DS; Obritsch WF; Donoso LA
J Immunol; 1993 Nov; 151(10):5751-61. PubMed ID: 7693817
[TBL] [Abstract][Full Text] [Related]
10. Suppression of experimental autoimmune uveitis in Lewis rats by oral administration of recombinant Escherichia coli expressing retinal S-antigen.
Singh VK; Anand R; Sharma K; Agarwal SS
Cell Immunol; 1996 Sep; 172(2):158-62. PubMed ID: 8964076
[TBL] [Abstract][Full Text] [Related]
11. The immunopathogenesis of chronic and relapsing autoimmune uveitis - Lessons from experimental rat models.
Diedrichs-Möhring M; Kaufmann U; Wildner G
Prog Retin Eye Res; 2018 Jul; 65():107-126. PubMed ID: 29496590
[TBL] [Abstract][Full Text] [Related]
12. [Immunologic suppression of experimental autoimmune uveitis].
Thurau SR; Caspi RR; Chan CC; Weiner HL; Nussenblatt RB
Fortschr Ophthalmol; 1991; 88(4):404-7. PubMed ID: 1838532
[TBL] [Abstract][Full Text] [Related]
13. Spontaneously relapsing-remitting experimental autoimmune uveitis in rats allows successful therapeutic oral tolerance induction in ongoing disease.
Huber A; Diedrichs-Möhring M; Wildner G
Mol Immunol; 2015 Feb; 63(2):215-26. PubMed ID: 25085538
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
